Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A randomized trial on the regular use of potent mouthwash in COVID-19 treatment

View ORCID ProfileKhalid Mukhtar, Suelen Qassim, Shaikha Ali Al Qahtani, Mohamed Ibn-Masud Danjuma, Mohamed Mohamedali, Housamaddeen Al Farhan, Mohammed F. Khudair, Abdel Rehim El Tayeh, Mohammed Al-Dosari, Mohamed Elhassan Babiker, Ahmed Hassib, Rumaisa Mohamed Elmustafa, Wesal Elhadary, Morwan Abdulkarim, Rajvir Singh, Muna Al.Maslamani
doi: https://doi.org/10.1101/2020.11.27.20234997
Khalid Mukhtar
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Khalid Mukhtar
  • For correspondence: kmukhter@hamad.qa
Suelen Qassim
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaikha Ali Al Qahtani
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Ibn-Masud Danjuma
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Mohamedali
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Housamaddeen Al Farhan
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed F. Khudair
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdel Rehim El Tayeh
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Al-Dosari
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Elhassan Babiker
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Hassib
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rumaisa Mohamed Elmustafa
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wesal Elhadary
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morwan Abdulkarim
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajvir Singh
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muna Al.Maslamani
1,3,4,5,6,7,8,9,10,11,12,13,14,15,16Hamad Medical Corporation, Doha, QATAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

1. Abstract

In this work we tried to study the effect of the regular use of potent mouthwash in COVID19 cases, on the premise that it may speedup the recovery, through the repeated reduction of microbial load, of both, the 2019-nCOV and oral microbiota; thus slowing the disease progression and lowering the incidence of superinfections.

Through a randomized controlled trial, a mixed solution of Hydrogen peroxide 2% and chlorhexidine gluconate, to be used for oral rinsing and gargling three times daily, was tested in cases admitted to COVID treatment facility, versus the standard (only) COVID19-treatment protocol, starting with 46 cases in each group, matched in terms of disease severity, of symptoms, and average cycle threshold value (CT-value) for the COVID PCR test on diagnosis.

Our findings showed statistically significant improvement in terms of a higher conversion rate to “COVID19-negative PCR” by five days of treatment (6/46 Vs 0/46), improvement in “symptoms severity” after two days of treatment, and less intubation and mortality (0/46 Vs 3/46) with all P-value < 0.05. There was also a trend of improvement in other outcome variables, though with no statistically significant difference; namely “shorter hospital stays,” “less progression in Oxygen requirements”, “less rate of plasma transfusion”, and better “gross extent of improvement”.

Our findings support a beneficial role in treating active cases (Disease) and anticipates better outcome should implemented earlier in course of the disease; thus, suggest a role in limiting the spread (Pandemic), as an additional preventive method. Additionally, we think the repeated reduction in the microbial load might have been sufficient to induce a strain in a possible viral-microbial interaction, resulting in slowing down of the disease progress.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN10197987 https://doi.org/10.1186/ISRCTN10197987

Funding Statement

The study is funded by Hamad Medical Corporation’s Medical Research Center

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Hamad Medical Corporation - Medical Research Center- IRB

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • sq1513914{at}student.qu.edu.qa

  • SALQAHTANI4{at}hamad.qa

  • mdanjuma{at}hamad.qa

  • mmohamedali{at}hamad.qa

  • halfarhan1{at}hamad.qa

  • mkhudhair{at}hamad.qa

  • aeltayeh{at}hamad.qa

  • maldosari1{at}hamad.qa

  • mbabiker{at}hamad.qa

  • ahassib1{at}hamad.qa

  • rmohamed31{at}hamad.qa

  • welhadary{at}hamad.qa

  • mabdulkrim{at}hamad.qa

  • rsingh{at}hamad.qa

  • malmaslamani{at}hamad.qa

  • Multiple corrections were requested upon submission attempts to multiple journals, including the count of words, figures and tables, in addition to the writing style; such as "ambiguity of some terms", and details about the methodology.

Data Availability

The Data sheet referenced in the manuscript is to be shared only with a publishing journal, after signing a Data sharing agreement

https://www.isrctn.com/ISRCTN10197987

  • 2. Abbreviations and Acronyms

    RTI
    Respiratory Tract Infection
    COVID19
    novel Coronavirus disease 2019
    2019-nCOV
    the novel coronavirus that causes severe acute respiratory illness/ Syndrome
    RT-PCR
    Reverse transcription Polymerase Chain reaction
    CT
    Cycle threshold value; the number of amplification cycles required to reach a fixed (fluorescent) signal to cross the threshold (i.e., exceeds background level).
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted April 25, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    A randomized trial on the regular use of potent mouthwash in COVID-19 treatment
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    A randomized trial on the regular use of potent mouthwash in COVID-19 treatment
    Khalid Mukhtar, Suelen Qassim, Shaikha Ali Al Qahtani, Mohamed Ibn-Masud Danjuma, Mohamed Mohamedali, Housamaddeen Al Farhan, Mohammed F. Khudair, Abdel Rehim El Tayeh, Mohammed Al-Dosari, Mohamed Elhassan Babiker, Ahmed Hassib, Rumaisa Mohamed Elmustafa, Wesal Elhadary, Morwan Abdulkarim, Rajvir Singh, Muna Al.Maslamani
    medRxiv 2020.11.27.20234997; doi: https://doi.org/10.1101/2020.11.27.20234997
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    A randomized trial on the regular use of potent mouthwash in COVID-19 treatment
    Khalid Mukhtar, Suelen Qassim, Shaikha Ali Al Qahtani, Mohamed Ibn-Masud Danjuma, Mohamed Mohamedali, Housamaddeen Al Farhan, Mohammed F. Khudair, Abdel Rehim El Tayeh, Mohammed Al-Dosari, Mohamed Elhassan Babiker, Ahmed Hassib, Rumaisa Mohamed Elmustafa, Wesal Elhadary, Morwan Abdulkarim, Rajvir Singh, Muna Al.Maslamani
    medRxiv 2020.11.27.20234997; doi: https://doi.org/10.1101/2020.11.27.20234997

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (179)
    • Allergy and Immunology (434)
    • Anesthesia (99)
    • Cardiovascular Medicine (948)
    • Dentistry and Oral Medicine (178)
    • Dermatology (109)
    • Emergency Medicine (260)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
    • Epidemiology (8983)
    • Forensic Medicine (4)
    • Gastroenterology (420)
    • Genetic and Genomic Medicine (1953)
    • Geriatric Medicine (190)
    • Health Economics (401)
    • Health Informatics (1328)
    • Health Policy (659)
    • Health Systems and Quality Improvement (519)
    • Hematology (212)
    • HIV/AIDS (420)
    • Infectious Diseases (except HIV/AIDS) (10801)
    • Intensive Care and Critical Care Medicine (575)
    • Medical Education (200)
    • Medical Ethics (54)
    • Nephrology (222)
    • Neurology (1827)
    • Nursing (110)
    • Nutrition (272)
    • Obstetrics and Gynecology (353)
    • Occupational and Environmental Health (470)
    • Oncology (997)
    • Ophthalmology (297)
    • Orthopedics (111)
    • Otolaryngology (182)
    • Pain Medicine (126)
    • Palliative Medicine (44)
    • Pathology (265)
    • Pediatrics (579)
    • Pharmacology and Therapeutics (275)
    • Primary Care Research (234)
    • Psychiatry and Clinical Psychology (1898)
    • Public and Global Health (4122)
    • Radiology and Imaging (675)
    • Rehabilitation Medicine and Physical Therapy (368)
    • Respiratory Medicine (548)
    • Rheumatology (224)
    • Sexual and Reproductive Health (190)
    • Sports Medicine (177)
    • Surgery (207)
    • Toxicology (39)
    • Transplantation (109)
    • Urology (80)